title: Pregabalin for the treatment of painful hand-foot skin reaction associated with dabrafenib.
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Evelyn
authors.initials: E
authors.lastname: Lilly
authors.affiliation: Yale Comprehensive Cancer Center, New Haven, Connecticut.
authors.forename: Matthew
authors.initials: M
authors.lastname: Burke
authors.affiliation: Yale Comprehensive Cancer Center, New Haven, Connecticut.
authors.forename: Harriet
authors.initials: H
authors.lastname: Kluger
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut2Yale Comprehensive Cancer Center, New Haven, Connecticut.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Choi
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D060831:Hand-Foot Syndrome / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010091:Oximes / Q000008:administration & dosage / Q000009:adverse effects*; D000069583:Pregabalin; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000700:Analgesics; D000970:Antineoplastic Agents; D007093:Imidazoles; D010091:Oximes; D047428:Protein Kinase Inhibitors; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; C561627:dabrafenib